<div id="readability-page-1"><p>Kepler Capital  analyst David Evans maintained a Buy rating on Novartis AG on May 8 and set a price target of CHF135.00. The company’s shares closed last Friday at CHF113.36.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>According to TipRanks, Evans is ranked #7060 out of 12193 analysts.</p> <p>In addition to Kepler Capital , Novartis AG also received a Buy from Bank of America Securities’s Sachin Jain in a report issued on May 7. However, on May 8, UBS maintained a Hold rating on Novartis AG (Six Swiss: NOVN).</p></div>

<p>Kepler Capital analyst David Evans has maintained a Buy rating on Novartis AG (NOVN) as of May 8, with a price target of CHF135.00. The stock closed at CHF113.36 last Friday. Additionally, Bank of America Securities also issued a Buy rating on Novartis AG, while UBS maintained a Hold rating on the same date.</p>

Tip Ranks

Novartis AG

NOVARTIS AG

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

VG Health

ALPS Medical Breakthrough

Health Care Select Sector SPDR

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bull 3X

iShares Global Healthcare

Ark Genomic Revolution ETF

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Bank of America

UBS Group AG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Kepler Capital  Remains a Buy on Novartis AG (NOVN)